Recreational use of HIV drugs leading to pre-treatment resistance in South Africa

NPR's "Shots" blog examines how "[o]pportunists who market street drugs may be undermining the global struggle against AIDS," writing, "In South Africa, two mainstay HIV drugs have found their way into recreational use." According to the blog, "[p]eople with HIV who smoke so-called whoonga -- an illicit concoction of an AIDS medication and a street drug, like marijuana or heroin -- can develop mutant strains of the virus resistant to the medication," or "people can become infected with a strain of HIV that came from someone who used whoonga."

"'One large study showed 3 to 5 percent of people with HIV were coming in with pre-treatment resistance' to antiretroviral drugs used to treat HIV, [said] Dr. David Grelotti ..., a Harvard School of Public Health researcher who co-authored a commentary on the phenomenon in the Lancet Infectious Diseases published Tuesday," the blog notes. "Recreational use of HIV drugs isn't altogether new, though it hasn't had much attention," "Shots" writes, noting, "Some media reports documented illicit use of HIV drugs in South Africa as long ago as 2009." The blog adds, "Aside from the resistance problem, illicit use of HIV drugs poses other dangers," as "recreational use can make legitimate users of these drugs, and the clinics that dispense them, targets of thieves and violent crime" (Knox, 12/18).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Historical redlining continues to affect HIV treatment in affected communities